Nyxoah S.A.

NasdaqGM:NYXH Stock Report

Market Cap: US$313.0m

Nyxoah Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Olivier Taelman

Chief executive officer

€807.1k

Total compensation

CEO salary percentage54.1%
CEO tenure5yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure4.5yrs

Recent management updates

Recent updates

Nyxoah inks distribution deal for Acurable's sleep test AcuPebble in Germany

Aug 02

Nyxoah jumps 31% on FDA nod to start trial for sleeping disorder

Jul 11

CEO Compensation Analysis

How has Olivier Taelman's remuneration changed compared to Nyxoah's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-€53m

Jun 30 2024n/an/a

-€44m

Mar 31 2024n/an/a

-€43m

Dec 31 2023€807k€436k

-€43m

Sep 30 2023n/an/a

-€46m

Jun 30 2023n/an/a

-€44m

Mar 31 2023n/an/a

-€36m

Dec 31 2022€631k€436k

-€31m

Sep 30 2022n/an/a

-€24m

Jun 30 2022n/an/a

-€27m

Mar 31 2022n/an/a

-€29m

Dec 31 2021€731k€413k

-€28m

Sep 30 2021n/an/a

-€25m

Jun 30 2021n/an/a

-€21m

Mar 31 2021n/an/a

-€16m

Dec 31 2020€336k€263k

-€12m

Compensation vs Market: Olivier's total compensation ($USD840.46K) is below average for companies of similar size in the US market ($USD2.24M).

Compensation vs Earnings: Olivier's compensation has increased whilst the company is unprofitable.

CEO

Olivier Taelman (53 yo)

5yrs

Tenure

€807,096

Compensation

Mr. Olivier Taelman serves as a Vice President of Sales ­Europe at Autonomic Technologies, Inc. Mr. Olivier Taelman is the Chief Executive Officer at Nyxoah S.A. since November 2019 and serves as its Execu...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Taub
Co-Founder & Chairman15.3yrs€127.63k7.55%
$ 23.6m
Olivier Taelman
CEO & Executive Director5yrs€807.10kno data
Loic Moreau
President of Internationalno data€468.69k0.035%
$ 110.8k
John Landry
Chief Financial Officerno datano datano data
Bruno Onkelinx
Chief Technology Officer3.7yrsno datano data
Mikaela Kirkwood
Corporate Communication & Investor Relations Managerno datano datano data
An Moonen
General Counsel3.9yrsno datano data
Maggie McGowan
Chief HR Officerless than a yearno datano data
Remi Renard
Chief of Staffless than a yearno datano data
Jeyakumar Subbaroyan
Chief Clinical Officer1.1yrsno datano data
Francis Kim
Chief Regulatory & Quality Officerless than a yearno datano data
Maurits Boon
Chief Medical Officerless than a yearno datano data

0.9yrs

Average Tenure

53yo

Average Age

Experienced Management: NYXH's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Robert Taub
Co-Founder & Chairman15.3yrs€127.63k7.55%
$ 23.6m
Olivier Taelman
CEO & Executive Director4.2yrs€807.10kno data
Kevin Rakin
Independent Non-Executive Director8.4yrs€68.59k0.33%
$ 1.0m
Jurgen Hambrecht
Independent Non-Executive Director4.8yrs€58.50k3.59%
$ 11.3m
Daniel Wildman
Independent Non-Executive Director1.8yrs€71.28kno data
Virginia Kirby
Independent Non-Executive Director2.4yrs€59.22k0.015%
$ 46.5k
Rita Johnson-Mills
Independent Non-Executive Director3.3yrs€63.62k0.015%
$ 46.5k
Pierre Gianello
Non-Executive Director6.8yrs€175.63k0.031%
$ 96.8k

4.5yrs

Average Tenure

67yo

Average Age

Experienced Board: NYXH's board of directors are considered experienced (4.5 years average tenure).